How Empty Are Empty Reviews? The first report on the Empty Reviews Project sponsored by the Cochrane Opportunities Fund and an invitation to participate.

Slides:



Advertisements
Similar presentations
Evidence-based Dental Practice Developing guidelines or clinical recommendations Slide #1 This lecture follows the previous online lecture on evidence.
Advertisements

ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.
Technology Appraisal of Medical Devices at NICE – Methods and Practice Mark Sculpher Professor of Health Economics Centre for Health Economics University.
Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Research article structure: Where can reporting guidelines help? Iveta Simera The EQUATOR Network workshop.
Participation Requirements for a Guideline Panel Co-Chair.
Introducing... Reproduced and modified from a presentation produced by Zoë Debenham from the original presentation created by Kate Light, Cochrane Trainer.
Systematic Reviews Dr Sharon Mickan Centre for Evidence-based Medicine
External validity: to what populations do our study results apply?
Participation Requirements for a Patient Representative.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
Theme 6. Cochrane Reviews: innovative reviews and methodology.
Doug Altman Centre for Statistics in Medicine, Oxford, UK
Participation Requirements for a Guideline Panel PGIN Representative.
Transparency and accuracy in reporting health research Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK.
Reading the Dental Literature
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare.
© Grant Thornton UK LLP. All rights reserved. Review of Sickness Absence Vale of Glamorgan Council Final Report- November 2009.
European collaboration to identify reports of controlled trials in general and specialized health care journals published in Western Europe Gerd Antes.
James A. Hokanson, Ph.D. Department of Preventive Medicine and Community Health University of Texas Medical Branch.
The ICH E5 Question and Answer Document Status and Content Robert T. O’Neill, Ph.D. Director, Office of Biostatistics, CDER, FDA Presented at the 4th Kitasato-Harvard.
PPA 502 – Program Evaluation
C ONSUMER PARTICIPATION IN T HE C OCHRANE C OLLABORATION : A COMPARISON OF MODELS Gill Gyte Dell Horey 20 October 2011.
O Type 2 diabetes has traditionally been managed as a single chronic disease state but it can commonly exist with co-morbidities such as depression. o.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
THE COCHRANE LIBRARY ON WILEY INTERSCIENCE. Presentation Agenda Brief introduction of Evidence-Based Medicine theories The Cochrane Collaboration – origins,
1 ICEBOH Split-mouth studies and systematic reviews Ian Needleman 1 & Helen Worthington 2 1 Unit of Periodontology UCL Eastman Dental Institute International.
Systematic Reviews.
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
GCP & ETHICS COMMITTEES Ravi Rengachari Vector Control Research Centre PONDICHERRY.
Finding Relevant Evidence
Plymouth Health Community NICE Guidance Implementation Group Workshop Two: Debriding agents and specialist wound care clinics. Pressure ulcer risk assessment.
Clinical Writing for Interventional Cardiologists.
RevMan for Registrars Paul Glue, Psychological Medicine What is EBM? What is EBM? Different approaches/tools Different approaches/tools Systematic reviews.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Rachel Marshall and Sally Hopewell Cochrane Editorial Unit and Centre for Statistics in Medicine, University of Oxford and French Cochrane Centre. Friday.
Evidence Based Practice RCS /9/05. Definitions  Rosenthal and Donald (1996) defined evidence-based medicine as a process of turning clinical problems.
Methodological quality of malaria RCTs conducted in Africa Vittoria Lutje*^, Annette Gerritsen**, Nandi Siegfried***. *Cochrane Infectious Diseases Group.
Module 3 Finding the Evidence: Pre-appraised Literature.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
What evidence can help practice decisions about what works and what doesn’t? Elizabeth Waters Chair in Public Health School of Health and Social Development,
Research article structure: Where can reporting guidelines help? Iveta Simera The EQUATOR Network workshop 10 October 2012, Freiburg, Germany.
1 National Forum on Biomedical Imaging in Oncology CMS UPDATE Steve Phurrough MD, MPA Director, Coverage and Analysis Group.
Incorporating economic perspectives and evidence into Cochrane reviews Dawn Craig Co-convenor Campbell & Cochrane Economics Methods Group.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Joanne Edwards Medical Information Manager ASCO Tech Assessment Update Commercial Implications & Promotional Guidance.
CONSORT 2010 Balakrishnan S, Pondicherry Institute of Medical Sciences.
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
Organizations of all types and sizes face a range of risks that can affect the achievement of their objectives. Organization's activities Strategic initiatives.
/ 42 1 Acupuncture or acupressure for pain management in labour. (review of systematic reviews)
ACCA/PAB/ICAJ/ICAC Practice Monitoring Reviews OVERVIEW OF FINDINGS 19 July 2014.
Ghada Aboheimed, Msc. Review the principles of an evidence based approach to clinical practice. Appreciate the value of EBM Describe the 5 steps of evidence.
Knowledge Translation for Policymakers
Sample Journal Club Your Name Here.
Uterovaginal Prolapse
Best Practice Systematic Review
Patient Involvement in the HTA Decision Making Process
Introduction to Evidence- Based Practice
Supplementary Table 1. PRISMA checklist
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
STROBE Statement revision
ICTMS Communicating Trial Results to participants
Centre for Evidence Based Intervention
The Cochrane Empty Reviews Meeting
How to apply successfully to the NIHR HTA Board?
How to conduct Effective Stage-1 Audit
What is a review? An article which looks at a question or subject and seeks to summarise and bring together evidence on a health topic. Ask What is a review?
The Cochrane Empty Reviews Meeting
Presentation transcript:

How Empty Are Empty Reviews? The first report on the Empty Reviews Project sponsored by the Cochrane Opportunities Fund and an invitation to participate in the development of reporting guidelines Joanne Yaffe, PhD, University of Utah Paul Montgomery, PhD, University of Oxford Sally Hopewell, PhD, UK Cochrane Centre Lindsay Shepard, MSc, University of Utah The Empty Reviews Project is funded by the Cochrane Opportunities Fund

Summary of Presentation The Problem of Empty Reviews Current State of Cochrane Empty Reviews and Apparent Direction of Travel How this Project Aims to Proceed Cochrane Contributor Inputs The Cochrane Empty Reviews Project

Introduction: Why study empty reviews? First, what do we mean by Empty Review? An empty review is a systematic review that reports no studies eligible for inclusion. The Cochrane Empty Reviews Project

Lack of high quality studies to address question posed. – Very narrow population – Very focused intervention – Outcomes that are not measured. Many plan empty reviews to justify new trials in response to funding policies. The Cochrane Empty Reviews Project How do systematic reviews come to be empty?

Policy-makers and practitioners report frustration in locating a review only to find that it has no included studies and is of limited utility for clinical decisions. Should observations be made based on excluded studies to provide decision-makers with some guidance? (following Lang, Edwards & Flieszer 2007) The Cochrane Empty Reviews Project

The Cochrane Handbook (2009) does not address the reporting of empty reviews specifically, although it does address excluded studies in general. The Cochrane Empty Reviews Project

“A Cochrane review includes a list of excluded studies, detailing any studies that a reader might plausibly expect to see among the included studies. This covers all studies that may on the surface appear to meet the eligibility criteria but on further inspection do not, and also those that do not meet all of the criteria but are well known and likely to be thought relevant by some readers. By listing such studies as excluded and giving the primary reason for exclusion, the review authors can show that consideration has been given to these studies. The list of excluded studies should be as brief as possible…” The Cochrane Empty Reviews Project Excluded Study Guidance in Cochrane Handbook (p. 154)

Concern: Empty reviews may leave decision-makers dependent on weaker research which may be presented without sufficient discussion of limitations. Concern: Empty reviews may fail to provide any implications either for practice or research. The Cochrane Empty Reviews Project

Empty Reviews Project Aim: To develop guidelines, in consultation with stakeholders and the editors of the Cochrane Handbook, for authors of reviews who do not find studies eligible for inclusion. The Cochrane Empty Reviews Project

Prevalence of Empty Reviews in The CDSR (as of 15 August 2010) Total reviews in The CDSR N= 4320 Total empty reviews in The CDSR N= 375 (8.7%) The Cochrane Empty Reviews Project

Number of Empty Reviews across CRGs The Cochrane Empty Reviews Project

Proportion of Empty Reviews across CRGs The Cochrane Empty Reviews Project

Empty Reviews by Year of First Publication The Cochrane Empty Reviews Project

Age of Empty Reviews in The CDSR Half of all empty reviews are 3 years or older, with some dating to Mean Age = 3.3 years (SD 3.4) The Cochrane Empty Reviews Project

Time since last update of Empty Revi ews 48.3% of all empty reviews have been updated within the last 2 years, but 5.9% (21) have not received an update in 7 years or longer. Mean Time since Update = 2.8 years (SD 2.2) The Cochrane Empty Reviews Project

How many excluded studies are listed in these empty reviews? 95 (25.3%) of empty reviews do not list excluded studies. The number of excluded studies ranges from 0 to 124. Mean number of excluded studies = 9.6 (SD 14.5) The Cochrane Empty Reviews Project

How many studies are listed as pending assessment? 360 (96.0%) of empty reviews do not list pending studies. The number of pending studies ranges from 0 to 9. Mean number of pending studies = 0.1 (SD 0.7) The Cochrane Empty Reviews Project

How many studies are listed as on-going? 338 (90.1%) of empty reviews do not list on-going studies. The number of on-going studies ranges from 0 to 4. Mean number of on-going studies = 0.1 (SD 0.5) The Cochrane Empty Reviews Project

How many reviews list no studies at all? 88 (23.5%) of empty reviews do not list any excluded, pending, or on-going studies. The Cochrane Empty Reviews Project

So what? So, what are the implications of all these empty reviews?  The lack of guidelines for reporting studies that have no included studies may result in inconsistently reported reviews.  Policy-makers and practitioners might not rely on Cochrane reviews for decision-making.  More importantly, however, the lack of guidelines for authors of empty reviews may result in less than useful conclusions and further, may misstate results. The Cochrane Empty Reviews Project

What do we mean by “less than useful conclusions”? The Cochrane Empty Reviews Project Less than useful conclusions.

What sorts of conclusions might be less than useful? Reference to single studies without appropriate caveats. Unsupported statements. No statements at all. The Cochrane Empty Reviews Project

Review A : Implications for practice Sufficient evidence based on randomised controlled trials is lacking and therefore we can draw no reliable conclusions about the comparative effectiveness of medical and surgical interventions of [deleted to de-identify]. However, the studies identified, but excluded from this review, suggest there may be a considerable response to placebo treatment in this condition. Review B: Implications for practice On the evidence currently available, [ ] cannot be recommended for the treatment of [ ]. Implications for research [ ] has shown promise in animal studies but there are no randomized double-blind placebo-controlled trials in people with [ ]. Such trials are needed. The Cochrane Empty Reviews Project

What might be better ways to handle conclusions? Specific recommendations for design of trials. Appeal to related reviews, drawing analogy to present question, with caveats. Balanced discussion of weaker studies. The Cochrane Empty Reviews Project

Review C: Implications for research 1.General As with all similar reviews, public registration of a study before anyone is randomised would ensure that participants could be confident that people would know that the study had at least taken place. Compliance with CONSORT (Moher 2001), both on the part of authors and editors, would help to clarify methodology and many outcomes. Failure to comply with CONSORT guidelines results in loss of data and confusion in results, neither of which helps clinicians, patients or managers Specific [ ] is a most distressing [ ] disorder that remains highly prevalent, both in the developed and developing world. This review highlights the need for well designed, conducted and reported clinical trials (Table 1) to address the claims of open studies as regards the effects of the [ ] group of drugs for [ ]. The Cochrane Empty Reviews Project

What do we hope to accomplish? Consistency in the way that excluded studies are addressed in the authors’ conclusions. Collaboration with other stakeholders towards development of guidelines for inclusion in The Cochrane Handbook. The Cochrane Empty Reviews Project

Our Plan 1.Complete our analysis of the 375 empty reviews in The CDSR as of 15 August, Solicit input from all interested parties via and (coming soon!). 3.Develop specific recommendations around the writing, presentation, and persistence in updating empty reviews. The Cochrane Empty Reviews Project

4.Present our findings and recommendations at a consensus meeting of key stakeholders in Spring, 2011, including Cochrane Handbook editors. 5.Use the results of the consensus meeting to refine our recommendations. 6.Present our findings to the Madrid Colloquium in October 2011, for further discussion. The Cochrane Empty Reviews Project

The Cochrane Empty Reviews Project Funded by The Cochrane Opportunities Fund Paul Montgomery, PhD, University of Oxford, PI Sally Hopewell, PhD, UK Cochrane Centre, Co-PI Joanne Yaffe, PhD, University of Utah, Co-PI Lindsay Shepard, MSc, University of Utah, Research Associate